Annual Report for thr FY 2025-26 along with Notice of AGM and all annexures thereto

Date: August 22, 2026 Asst. General Manager- Dept of Corp. Services, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai: 400001 Sub: Notice of Annual General Meeting to be held on Thursday, September 24, 2026 at 11.30 A.M (IST) through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”). Scrip ID: CTLLAB Scrip Code: 544220 Dear Sir/ Madam, In terms of provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find attached herewith a copy of the Annual Report including Notice of Annual General Meeting. Kindly note that Register of Members and Share transfer Books of the company will remain closed from Friday, September 18, 2026 to Thursday, September 24, 2026 (both days inclusive). You are requested to take a note of the same and oblige. Thanking You, Yours faithfully, For CLINITECH LABORATORY LIMITED Jagdish Umakant Nayak Chairman and Managing Director DIN: 00646672 Encl: as above CLINITECH LABORATORY LIMITED ANNUAL REPORT 2025-26 INDEX Sr. No. Content Page No. 1 General Information 2 2 Management Note 4 3 Notice of Annual General Meeting 6 4 Boards Report for FY 2025-26 23 5 Management Discussion and Analysis (Annexure I) 41 6 Particulars of Remuneration (Annexure II) 49 7 Particulars of Remuneration of Top 10 employees (Annexure III) 8 Form AOC-1 (Annexure IV) 53 9 Secretarial Audit Report (Annexure V) 55 10 Form AOC-2 (Annexure VI) 59 11 Independent Standalone Auditor’s Report (Annexure VII) 62 12 Standalone Financial Statements (Annexure VIII) 80 13 Independent Consolidated Auditor’s Report (Annexure 14 Consolidated Financial Statements (Annexure X) 104 CLINITECH LABORATORY LIMITED ANNUAL REPORT 2025-26 GENERAL INFORMATION Board of Directors: Chairman &Managing Director Mr. Jagdish Umakant Nayak Whole-Time Director Mrs. Jyoti Jagdish Nayak Non-Executive, Non-Independent Mr. Ashutosh Jagdish Nayak Director Mr. Ravikant Moreshwar Mhatre Non-Executive, Independent Mr. Balu Laxman Kumbharkar Director Ms. Smita Arjun Patil Executive Management: Chief Financial Officer Mr. Rahul Motilal Patil Mr. Bharat Kumar Bohra Company Secretary & Compliance (Resigned w.e.f. June 02, 2025) Officer Ms. Shruti Hemant Patankar (Appointed w.e.f. June 06, 2025) Auditor: Statutory Auditors (appointed at M/s. Kale Malde & Co. AGM held on July 11, 2024 for the Chartered Accountant FY 2023-24) Add: 1, Shivkrupa Building Patharli Road, Shelar Naka, Dombivali (East), Thane- 421201. Tel.:+91-9821292688/ +91-8692000600 E-Mail: alpesh1804@gmail.com Internal Auditor M/s. Kalpesh Khatri & Associates. Chartered Accountants (Appointed w.e.f March 25, 2025) Secretarial Auditor M/s. Deep Shukla & Associates Company Secretaries (Appointed w.e.f March 25, 2025) Bankers Bank of Baroda 7221, Airoli Sector 10 Branch Unit No-6, ground Fllor, Signia Oceans, Sector 10-A, Next to D-Mart, Airoli, Navi Mumbai- 400708. E-mail: Vjairo@bankofbaroda.com Registered Office AL-1/545, Sector 16, Airoli, Opposite Radhikabai Meghe Vidyalaya, Thane, Navi Mumbai, Maharashtra, India, 400708 Phone: +91 22 45003240/ +91 9004072223 CLINITECH LABORATORY LIMITED ANNUAL REPORT 2025-26 E-Mail:- jagdishnayak.ctl@gmail.com/compliance@clinitechlab.com accounts@ctllab.in/cfo@clinitechlab.com Website: https://ctllab.in/ Registrar and Share Transfer Agent M/s. Bigshare Services Private Limited Office No S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai – 400093 Phone: 022 – 62638200, FAX: 022 – 62638299 E-mail:- info@bigshareonline.com Website: www.bigshareonline.com CLINITECH LABORATORY LIMITED ANNUAL REPORT 2025-26 MANAGEMENT NOTE Dear Shareholders, The financial year 2025-26 marked another significant milestone in the journey of Clinitech Laboratory Limited. As the Company completed its second year as a listed entity on the BSE SME Platform, we continued to focus on strengthening our market position, enhancing operational efficiencies, expanding our service offerings, and creating sustainable value for all stakeholders. It is our privilege to write to you and present the 16th Annual Report for financial year 2025-26, marking our second year as a publicly listed company. Our Company is in the business of healthcare services which continues to provide superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. We strive to help and cater to the medical needs of our patients in best possible way at all our 50+ branches and centres. Clinitech is committed to advance healthcare solutions for a better tomorrow. A Year of Expansion and Opportunity Despite a dynamic macroeconomic environment, our Company has delivered a strong operational and financial performance as a listed entity in this year. We remained focused on our core priorities: building sustainable growth, strengthening our operations, and driving innovation. We also focused on diversification and expansion of our business by incorporating two subsidiaries – Medicarenx Multispeciality Hospital Private Limited, hospital industry & Analog IVD Solutions Private limited, healthcare product distribution sector. The Company is confident of positive growth prospects in both its operating verticals, which are anticipated to collectively strengthen its business performance and support its overall growth trajectory. We have made tangible progress in- i. upgradation of our existing centre at Badlapur; ii. Grow our operations through new service agreements and collaborations and iii. Diversification through our subsidiaries. These steps not only contributed to this year’s results but also lay a solid foundation for future growth. Strengthening Governance and Transparency Public listing brings with it, heightened responsibilities. We have embraced these with a clear focus on strengthening corporate governance, transparency, and compliance across all levels of the organization. We have also enhanced our disclosures, investor communications, and internal controls to align with the best practices expected of a listed company. CLINITECH LABORATORY LIMITED ANNUAL REPORT 2025-26 Looking Ahead We remain committed to creating long-term value for our shareholders and to building a resilient, innovative, and purpose-driven organization. As we look ahead, the management remains optimistic about the Company's growth trajectory and its ability to successfully capitalize on emerging opportunities within the healthcare diagnostics sector, hospital industry and healthcare product distribution sector. Acknowledgements I would like to thank our Board of Directors for their valuable guidance, our employees for their unwavering dedication, and our customers, partners, shareholders and all other stakeholders for their continued trust and support. I would also like to thank our professionals, auditors, merchant bankers, and other advisors for their unwavering support & valuable advice. The successful completion of our second year as a listed company is a testament to the collective efforts of all stakeholders. We remain committed to building a stronger, more resilient, and growth-oriented organization in the years ahead. Warm Regards, Jagdish Umakant Nayak Chairman & Managing Director CLINITECH LABORATORY LIMITED ANNUAL REPORT 2025-26 N O T I C E NOTICE is hereby given that the 16th Annual General Meeting of the Members of Clinitech Laboratory Limited will be held on Thursday, 24th September, 2026 at 11.30 A.M (IST) through Video Conferencing (“VC”), the venue of the meeting shall be deemed to be AL-1/545, Sector 16, Airoli, Opposite Radhikabai Meghe Vidyalaya, Thane-400708, Navi Mumbai, Maharashtra, India to transact the following business(es): ORDINARY BUSINESS: 1. Adoption of Audited Standalone & consolidated financial statements of the Company for the financial year ended March 31, 2026, and the reports of the Board of Directors and Auditors thereon: To consider and pass [Showing first 8,000 characters — download PDF for full document]